Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
SARILUMAB
Kevzara
Rheumatoid Arthritis
SARILL08755SariPRONCT03449758Tabulated Results
SARILUMAB
Kevzara
Rheumatoid Arthritis
SFY13370SARIL-RA-ASCERTAINEudraCT: 2012-003536-23Tabulated Results
SEMULOPARIN
Not Marketed
Venous Thromboembolism
DRI6243TREKNCT00331838Publication's reference
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC10342SAVE-HIP1NCT00697099Publication's reference
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC10343SAVE-HIP2NCT00721760Publication's reference
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC10571SAVE-KNEENCT00718224Publication's reference
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC10572SAVE-VEMEDEudraCT: 2008-000228-13Summary Results
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC10636SAVE-HIP3NCT00709904Publication's reference
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC6520SAVE-ABDOEudraCT: 2007-007942-36Summary Results
SEMULOPARIN
Not Marketed
Venous Thromboembolism
EFC6521SAVE-ONCONCT00694382Publication's reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted